Mindset Pharma Inc.
TORONTO, A6 · CIK 0001859156 · Biotech · Acquired
Psychedelic-derived therapeutic molecules for mental health disorders
otsuka-us.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $694K
- 1 Form D · Apr 2021
- 65 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 34
- 9 granted · 25 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20202021
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $694,347 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2153 | QRKANSWER LLC | — | — |
| 2154 | Valeo Pharma Inc. | — | $787K |
| 2155 | Falcon Therapeutics, Inc. | — | $700K |
| 2156 | Mindset Pharma Inc. | — | $694K |
| 2157 | Bitterroot Bio | — | — |
| 2158 | ASL Analytical, Inc. | — | $2.4M |
| 2159 | NOVAZOI THERANOSTICS | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Joseph AraujoDirector
- James LanthierExecutive Officer
- James PassinDirector
- Richard PatricioDirector
- Arvin RamosExecutive Officer
- Jessica WhittonExecutive Officer
- Philip WilliamsDirector
Patents
- Indole Derivatives As Serotonergic Agents Useful For The Treatment Of Disorders Related Theretoapplication
- Psilocin Derivatives As Serotonergic Psychedelic Agents For The Treatment Of Cns Disordersapplication
- Indole Derivatives As Serotonergic Agents Useful For The Treatment Of Disorders Related Theretogranted
- Indole Derivatives As Serotonergic Agents Useful For The Treatment Of Disorders Related Theretoapplication
- Scalable Synthetic Route For Psilocin And Psilocybingranted
- Indoline Derivatives As Serotonergic Agents Useful For The Treatment Of Disorders Related Theretoapplication
- Psilocin Derivatives As Serotonergic Psychedelic Agents For The Treatment Of Cns Disordersapplication
- Indoline Derivatives As Serotonergic Agents Useful For The Treatment Of Disorders Related Theretoapplication
- Indole Derivatives As Serotonergic Agents Useful For The Treatment Of Disorders Related Theretoapplication
- Psilocin Derivatives As Serotonergic Psychedelic Agents For The Treatment Of Cns Disordersgranted
- 3-CYCLOAMINO-INDOLE Compounds As Serotonergic Agents Useful For The Treatment Of Disorders Related Theretoapplication
- Indole Derivatives As Serotonergic Agents Useful For The Treatment Of Disorders Related Theretoapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.